73% of healthcare professionals (HCPs) report a disconnect between the availability of cutting-edge treatments and their effective implementation in clinical practice, while 3 in 4 oncologists say the rapid pace of new treatment development feels overwhelming. These insights reinforce Johnson…
BOTOX® Cosmetic Expands Commitment to Female Empowerment with The Confidence Project for Women Entrepreneurs In a bold move to champion female entrepreneurship and narrow the persistent confidence gap between men and women in business, Allergan Aesthetics, an AbbVie company (NYSE:…
Eli Lilly Reports Strong Q1 2025 Financial Results, Driven by Surging Demand for Mounjaro and Zepbound, While Advancing Pipeline Innovations Eli Lilly and Company (NYSE: LLY) has delivered a robust start to 2025, reporting a 45% year-over-year increase in revenue…
Crown Bioscience and NEXT Oncology Expand Strategic Partnership In a significant development that reinforces their shared vision for transforming cancer research and drug development, Crown Bioscience, a global contract research organization (CRO) under the umbrella of JSR Life Sciences and…
PCI Pharma Acquires Ajinomoto Althea as Part of $1B Investment to Boost U.S. Aseptic Fill-Finish Capacity PCI Pharma Services, a globally recognized contract development and manufacturing organization (CDMO) specializing in the development and commercialization of innovative biopharmaceutical therapies, has officially…
Verily Wins Michael J. Fox Foundation Grant to Build Major Parkinson’s Molecular Dataset In a significant development for neurodegenerative disease research, Verily, the Alphabet-owned precision health technology company, announced today that it has received a $14.7 million research grant from…
FUJIFILM Cellular Dynamics Names Delara Motlagh as Chief Operating Officer In a strategic move to enhance its operational leadership and accelerate the growth of its cutting-edge platforms in induced pluripotent stem cells (iPSCs) and cell therapy, FUJIFILM Cellular Dynamics, Inc.,…
Creyon Bio and Eli Lilly Forge Partnership to Develop RNA-Targeted Oligonucleotide Therapies Creyon Bio, Inc., a leader in innovative RNA-targeted therapies, has announced a transformative global licensing and multi-target research collaboration with Eli Lilly and Company, one of the world’s…
Qualthera Health Launches R&D Subsidiary for Drug Repurposing and Novel Delivery Qualthera Pharmaceuticals Ltd. Co. aims to reshape the future of therapeutics through a patient-driven, data-informed approach to repurposing proven compounds and revolutionizing drug delivery systems. Qualthera Health Corporation, a…
IFF Pharma Solutions Set to Highlight Its Portfolio at Excipient World 2025 IFF Pharma Solutions, a division of International Flavors & Fragrances Inc. and a global leader in polymer innovation, is preparing to take center stage at Excipient World 2025.…
Prilenia and Ferrer Partner on Pridopidine Commercialization and Development in Europe Prilenia Therapeutics B.V., a clinical-stage biopharmaceutical company dedicated to developing transformative therapies for neurodegenerative diseases, announced a significant new collaboration and license agreement with Ferrer, an international pharmaceutical company…
Revolution Medicines Shares Early Zoldonrasib Data in KRAS G12D NSCLC at 2025 AACR Revolution Medicines, Inc. a late-stage clinical oncology company committed to developing targeted therapies for patients with RAS-addicted cancers, today unveiled new clinical data on zoldonrasib (RMC-9805), a…
